Posted: December 21, 2021 at 6:39 pm TWG Source BioNTech\’s mRNA Cancer Vaccine Has Started Phase 2 Clinical Trial Colorectal cancer was chosen by BioNTech as an experimental vaccine target due to the disease\’s relatively high relapse rate. Via Leave a Reply Cancel replyYou must be logged in to post a comment.